Oct 3, 2022
Depression and New Therapies that are being developed to treat it
People of all ages are susceptible to the fairly prevalent disease known as depression. It ranks among the main global causes of disability. A serious condition with devastating effects.
It results in a decline in quality of life, melancholy, anxiety, guilt-inducing feelings, memory and reasoning problems, and, in the absence of prompt intervention, suicide.
Depression has a significant negative impact on how a person interprets information and makes them make poor decisions. Diabetes and heart disease can also be brought on by it.
Since 1957, medications including imipramine, a tricyclic antidepressant, and monoamine have been available to treat clinical depression.
Over time, an increasing number of medications were made available to treat the symptoms of depression, and the majority of these medications worked by raising dopamine levels.
But despite the existence of all these treatments, depression is still a common condition. This is because the effectiveness of pharmaceuticals is limited.
Therefore, it is important to create new therapeutic approaches.
New Found Hope in Stem Cell Based Therapies to combat depression
More medical professionals and researchers are now convinced that stem cell therapy can help us better understand depression, and its symptoms, and perhaps even find ways to treat some of its more severe effects.
The use of stem cell-based therapies is perceived as realistic, safe, and an effective strategy for handling cases of depression.
Over the past 60 years, a significant study has been done to better understand the causes of depression.
Finding the primary causes of depression and the neurological processes that produce depression are the objectives.
Inflammation and chronic stress are one of the biggest factors that lead to depression. A person exposed to frequent stress, without the ability to resolve them can suffer from neuroinflammation.
Frequent social stress, also increases fatigue and affects the brain regions negatively, especially if accompanied by social and rejection behaviors in the environment.
While adversities in life have a tendency to encourage growth and skill development in people.
Long-term depression is caused by a person’s inability to cope with and draw good conclusions from their experiences, which causes inflammation in the body and brain.
Anti-inflammatory and anti-depressant drugs help in curing symptoms of depression, however, further investigations are needed to evaluate their safety over a period of time.
Adult Stem Cells and Depression
Research investigations are now suggesting the potential use of adult stem cell therapy to cure Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, dementia, and epilepsy by way of transplantation of bone marrow mononuclear cells. Previous studies have shown significant improvements in neurological function. The transplanted stem cell therapy led to a decrease in inflammation and promoted tissue repair.
Clinical Trials in Depressive Patients
There is a great reason to believe that Stem cell therapy would one-day aid in reducing severe cases of depression. Experimental models have shown beneficial effects on depression, but there are gaps remaining to be explored.
Mesenchymal stem cells sourced from bone marrow contain the best potential to cure depression. There are just ethical issues to be resolved when it comes to autologous transplants that require surgical intervention to get hold of these cells.
There is also the need to assess the safety of using these cells from other donors with varying genetic backgrounds than the patient. Doctors need to determine the optimal doses needed to be administered before offering it for massive human use.
Technology is steadily evolving, and cells or cell-based products are improving. In the coming years, it will have lower costs and will become available for use especially now that more people are advocating for its exploration and use.
Feeling Good at Any Age The One-Stop Rejuvenation Center is a world leader in stem cell therapy and immunotherapy. FGAAA offers cutting-edge and revolutionary procedures such as stem cell infusion, HGH, HRT, and Reluma Cosmetics.
FGAAA has stringent criteria on what stem cells they use in their treatments. They only utilize premium when it comes to stem cell therapies. A strict evaluation process happens to ensure the best interest of patients. The clinic offers potent stem cells that provide effective healing potential.
Stem Cell Advocates
Lourdes Duque Baron, an actress-singer, film producer, and author, and Michael York are staunch supporters of stem cell research.
Stem cell therapy has resulted in incremental improvements that allow Lourdes Duque Baron and Michael York to continue living with incredible energy and immune systems.
Recipients of billions of stem cells attest to the truth and efficacy of this revitalizing and enormously powerful treatment.
Michael York, a well-known actor, became an advocate for stem cells after being treated for Amyloidosis and Multiple Myeloma.
While Lourdes Duque Baron received stem cell therapy to treat her osteoporosis.
New Breed of Homo Sapiens Book
A new book about Stem Cells and their wonders was authored by Lou Baron and will soon be released.
New Breed of Homo Sapiens Book Cover
“ Age should not define what you can do best to create a better world for humanity to thrive upon without fear of old age and other symptoms of age-related degenerative diseases”- Lou Baron
Said book is based on years of painstaking research and recent discoveries on stem cell therapy pioneered by her better half, Dr. Baron, an esteemed general, robotic, and stem cell surgeon.
The book’s goal is to educate people about the direction and to get stem cells accepted in the mainstream. Stem cell therapy has the potential to transform the healthcare system as we know it.
Sources:
- Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–138. [PubMed] [DOI] [Cited in This Article: 1] [Cited by in Crossref: 1054] [Cited by in F6Publishing: 1137] [Article Influence: 117.1] [Reference Citation Analysis (0)]
2. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lépine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. [PubMed] [DOI] [Cited in This Article: 1] [Cited by in Crossref: 908] [Cited by in F6Publishing: 976] [Article Influence: 82.5] [Reference Citation Analysis (0)]
3. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. [PubMed] [DOI] [Cited in This Article: 1] [Cited by in Crossref: 3190] [Cited by in F6Publishing: 3455] [Article Influence: 455.7] [Reference Citation Analysis (0)]
Do Prado-Lima PAS, Costa-Ferro ZSM, Souza BSF, da Cruz IBM, Lab B. Is there a place for cellular therapy in depression? World J Psychiatr 2021; 11(9): 553–567 [PMID: 34631460 DOI: 10.5498/wjp.v11.i9.553]
